-
1 Comment
Swissmed Centrum Zdrowia S.A. is currently in a long term uptrend where the price is trading 31.5% above its 200 day moving average.
Swissmed Centrum Zdrowia S.A.'s total revenue rose by 16.2% to $9M since the same quarter in the previous year.
Its net income has increased by 56.3% to $-769K since the same quarter in the previous year.
Finally, its free cash flow grew by 117.6% to $425K since the same quarter in the previous year.
Based on the above factors, Swissmed Centrum Zdrowia S.A. gets an overall score of 4/5.
| Exchange | WAR |
|---|---|
| CurrencyCode | PLN |
| ISIN | PLSWMED00013 |
| Industry | Medical Care Facilities |
| Sector | Healthcare |
| PE Ratio | None |
|---|---|
| Target Price | None |
| Dividend Yield | 0.0% |
| Market Cap | 67M |
| Beta | 1.49 |
Swissmed Centrum Zdrowia S.A. provides medical services in the field of basic medical care, specialist diagnostics, and hospital treatment through its clinics and hospitals in Poland. It offers hospital treatment services comprising ophthalmology, gynecology, orthopedics, urology, pediatric surgery, general surgery, plastic surgery, and performing surgical procedures as part of the specialties. The company operates clinics offering diagnostic tests and providing medical advice in the field over a dozen fields of medicine. It also provides rehabilitation and stay services. The company was founded in 1996 and is headquarters in Gdansk, Poland. As of September 15, 2021, Swissmed Centrum Zdrowia S.A. operates as a subsidiary of LUX MED Sp. z o.o.
Learn MoreHere's how to backtest a trading strategy or backtest a portfolio for SWD.WAR using our backtest tool. PyInvesting provides the backtesting software for you to backtest your investment strategy. Our backtest software is written using Python code and allows you to backtest stock, backtest etf, backtest options, backtest crypto and backtest forex online. Our backtesting Python framework is highly robust and gives you a realistic simulation of how your strategy would have performed in the past using backtest data.
© PyInvesting 2025
